News Daily News Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows Todd Neale December 14, 2015
News Daily News Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy L.A. McKeown September 21, 2015
News Industry News Medicure Announces Filing of sNDA for New AGGRASTAT® Indication September 10, 2015
News Conference News ESC 2015 MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI Yael L. Maxwell September 02, 2015
News Daily News Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers August 27, 2015
News Industry News Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada July 22, 2015
News Industry News The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin) July 09, 2015
News Daily News Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI June 09, 2015
News Daily News Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone L.A. McKeown April 28, 2015
News Conference News ACC 2015 MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin Todd Neale March 17, 2015
News Daily News Tanto una Dosis Segura como el Uso basado en las Directrices de los Antitrombóticos se asocia a los Resultados del SCASEST Yael L. Maxwell March 04, 2015
News Daily News Both Dosing Safety, Guideline-Based Use of Antithrombotics Related to NSTE-ACS Outcomes Yael L. Maxwell March 04, 2015
News Daily News SCAAR: Stent Thrombosis Risk After Primary PCI No Higher With Bivalirudin Than Other Antithrombotics Todd Neale February 19, 2015
News Daily News Outcomes Do Not Suffer With Shortened Eptifibatide Infusion During PCI Todd Neale January 28, 2015
News Daily News Un Análisis Conjunto a Nivel del Paciente Avala el Uso de Bivalirudina en PCI Primarias Yael L. Maxwell January 12, 2015
News Daily News Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI Yael L. Maxwell January 12, 2015
News Conference News TCT 2014 EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion September 14, 2014